SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 168 filers reported holding SHOCKWAVE MED INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $416,964 | -7.2% | 1,923 | -12.0% | 0.02% | +5.0% |
Q4 2022 | $449,463 | -24.4% | 2,186 | +2.3% | 0.02% | -31.0% |
Q3 2022 | $594,236 | +46.8% | 2,137 | +0.9% | 0.03% | +61.1% |
Q2 2022 | $404,707 | -7.8% | 2,117 | 0.0% | 0.02% | +12.5% |
Q1 2022 | $438,981 | -71.3% | 2,117 | -75.3% | 0.02% | -23.8% |
Q4 2021 | $1,530,785 | -15.9% | 8,584 | -2.9% | 0.02% | -19.2% |
Q3 2021 | $1,820,597 | +4.3% | 8,843 | -3.9% | 0.03% | +4.0% |
Q2 2021 | $1,745,516 | +70.5% | 9,200 | +17.0% | 0.02% | +66.7% |
Q1 2021 | $1,023,974 | +20.2% | 7,861 | -4.3% | 0.02% | +15.4% |
Q4 2020 | $851,541 | +36.8% | 8,210 | 0.0% | 0.01% | +18.2% |
Q3 2020 | $622,318 | +56.8% | 8,210 | -2.0% | 0.01% | +57.1% |
Q2 2020 | $396,961 | +47.6% | 8,380 | +3.4% | 0.01% | +16.7% |
Q1 2020 | $268,957 | -24.5% | 8,106 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $356,016 | +315.9% | 8,106 | +183.4% | 0.01% | +500.0% |
Q3 2019 | $85,600 | +140.3% | 2,860 | +358.3% | 0.00% | 0.0% |
Q2 2019 | $35,624 | – | 624 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
Matisse Capital | 22,175 | $4,415,043 | 3.12% |
Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
AtonRa Partners | 4,374 | $870,863 | 1.83% |
Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |